Association Between 10-Year Fracture Probability and Nonalcoholic Fatty Liver Disease With or Without Sarcopenia in Korean Men: A Nationwide Population-Based Cross-Sectional Study
- PMID: 33868162
- PMCID: PMC8044878
- DOI: 10.3389/fendo.2021.599339
Association Between 10-Year Fracture Probability and Nonalcoholic Fatty Liver Disease With or Without Sarcopenia in Korean Men: A Nationwide Population-Based Cross-Sectional Study
Abstract
Objective: Nonalcoholic fatty liver disease (NAFLD) and sarcopenia, which are common in elderly men, are known as risk factors of fracture. However, few studies have examined the association with fracture in these patients. Therefore, we aimed to investigate the association between NAFLD with or without sarcopenia and 10-year fracture probability in Korean men aged ≥50 years.
Materials and methods: Data of 2,525 individuals from the 2010-2011 Korea National Health and Nutrition Examination Survey were analyzed. NAFLD was defined using the fatty liver index (FLI) and comprehensive NAFLD score (CNS), and liver fibrosis using the fibrosis 4 calculator. Sarcopenia was defined as the lowest quintile for sex-specific sarcopenia index cutoff; values. The Fracture Risk Assessment (FRAX) tool was used to predict the 10-year probability of major osteoporotic and hip fractures.
Results: Compared to the no NAFLD group, the 10-year major osteoporotic fracture probability was significantly associated with the FLI-defined (β = 0.16, P = 0.002) and CNS-defined (β = 0.20, P < 0.001) NAFLD groups with liver fibrosis. Similarly, the 10-year hip fracture probability was significantly associated with the FLI- and CNS-defined NAFLD with liver fibrosis groups compared to the group without NAFLD (FLI-defined group, β = 0.04, P = 0.046; CNS-defined group, β = 0.05, P = 0.048). Furthermore, in the group with sarcopenia, the 10-year major osteoporotic fracture probability was significantly associated with the FLI- and CNS-defined NAFLD with liver fibrosis groups compared to the group without NAFLD (FLI-defined group, β = 0.29, P = 0.003; CNS-defined group, β = 0.38, P < 0.001).
Conclusions: NAFLD with liver fibrosis is significantly associated with a higher 10-year major osteoporotic and hip fracture probability in Korean men aged ≥50 years, and this positive association was more profound in patients with sarcopenia. Therefore, screening middle-aged to elderly men who have NAFLD combined with liver fibrosis and sarcopenia may help prevent fractures.
Keywords: 10-year fracture probability; fracture risk assessment tool; liver fibrosis; nonalcoholic fatty liver disease; sarcopenia.
Copyright © 2021 Lee, Lee and Kim.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be constructed as a potential conflict of interest.
Figures
Similar articles
-
Nonalcoholic Fatty Liver Disease and Sarcopenia Are Independently Associated With Cardiovascular Risk.Am J Gastroenterol. 2020 Apr;115(4):584-595. doi: 10.14309/ajg.0000000000000572. Am J Gastroenterol. 2020. PMID: 32141917
-
Low skeletal muscle mass is associated with non-alcoholic fatty liver disease in Korean adults: the Fifth Korea National Health and Nutrition Examination Survey.Hepatobiliary Pancreat Dis Int. 2016 Feb;15(1):39-47. doi: 10.1016/s1499-3872(15)60030-3. Hepatobiliary Pancreat Dis Int. 2016. PMID: 26818542
-
Sarcopenia combined with FRAX probabilities improves fracture risk prediction in older Chinese men.J Am Med Dir Assoc. 2014 Dec;15(12):918-23. doi: 10.1016/j.jamda.2014.07.011. Epub 2014 Sep 24. J Am Med Dir Assoc. 2014. PMID: 25262197
-
The role of sarcopenia in the risk of osteoporotic hip fracture.Clin Rheumatol. 2015 Oct;34(10):1673-80. doi: 10.1007/s10067-015-2943-9. Epub 2015 Apr 26. Clin Rheumatol. 2015. PMID: 25912213 Review.
-
Sarcopenia and risk of nonalcoholic fatty liver disease: A meta-analysis.Saudi J Gastroenterol. 2018 Jan-Feb;24(1):12-17. doi: 10.4103/sjg.SJG_237_17. Saudi J Gastroenterol. 2018. PMID: 29451179 Free PMC article. Review.
Cited by
-
The associations of alcoholic liver disease and nonalcoholic fatty liver disease with bone mineral density and the mediation of serum 25-Hydroxyvitamin D: A bidirectional and two-step Mendelian randomization.PLoS One. 2023 Oct 19;18(10):e0292881. doi: 10.1371/journal.pone.0292881. eCollection 2023. PLoS One. 2023. PMID: 37856513 Free PMC article.
-
Serum Insulin-Like Growth Factor 1 Levels, Facture Risk Assessment Tool Scores and Bone Disorders in Patients with Primary Biliary Cholangitis.Diagnostics (Basel). 2022 Aug 12;12(8):1957. doi: 10.3390/diagnostics12081957. Diagnostics (Basel). 2022. PMID: 36010307 Free PMC article.
-
Non-Alcoholic Fatty Liver Disease and Bone Tissue Metabolism: Current Findings and Future Perspectives.Int J Mol Sci. 2023 May 8;24(9):8445. doi: 10.3390/ijms24098445. Int J Mol Sci. 2023. PMID: 37176153 Free PMC article. Review.
-
Effects of Metabolic Dysfunction-Associated Steatotic Liver Disease on Bone Density and Fragility Fractures: Associations and Mechanisms.J Obes Metab Syndr. 2024 Jun 30;33(2):108-120. doi: 10.7570/jomes24004. Epub 2024 May 14. J Obes Metab Syndr. 2024. PMID: 38740429 Free PMC article. Review.
-
Editorial: Multi-organ linkage pathophysiology and therapy for NAFLD and NASH.Front Endocrinol (Lausanne). 2024 Jun 5;15:1418066. doi: 10.3389/fendo.2024.1418066. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38904044 Free PMC article. No abstract available.
References
-
- Kanis JA, McCloskey EV, Johansson H, Strom O, Borgstrom F, Oden A. Case finding for the management of osteoporosis with FRAX – assessment and intervention thresholds for the UK (2008). Available at: www.sheffield.ac.uk/FRAX (Accessed August 26, 2020). - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
